Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Practice Guideline
. 2008;15(1):41-54.
doi: 10.1007/s00534-007-1279-5. Epub 2008 Feb 16.

Guidelines for the management of biliary tract and ampullary carcinomas: surgical treatment

Collaborators, Affiliations
Practice Guideline

Guidelines for the management of biliary tract and ampullary carcinomas: surgical treatment

Satoshi Kondo et al. J Hepatobiliary Pancreat Surg. 2008.

Abstract

The only curative treatment in biliary tract cancer is surgical treatment. Therefore, the suitability of curative resection should be investigated in the first place. In the presence of metastasis to the liver, lung, peritoneum, or distant lymph nodes, curative resection is not suitable. No definite consensus has been reached on local extension factors and curability. Measures of hepatic functional reserve in the jaundiced liver include future liver remnant volume and the indocyanine green (ICG) clearance test. Preoperative portal vein embolization may be considered in patients in whom right hepatectomy or more, or hepatectomy with a resection rate exceeding 50%-60% is planned. Postoperative complications and surgery-related mortality may be reduced with the use of portal vein embolization. Although hepatectomy and/or pancreaticoduodenectomy are preferable for the curative resection of bile duct cancer, extrahepatic bile duct resection alone is also considered in patients for whom it is judged that curative resection would be achieved after a strict diagnosis of its local extension. Also, combined caudate lobe resection is recommended for hilar cholangiocarcinoma. Because the prognosis of patients treated with combined portal vein resection is significantly better than that of unresected patients, combined portal vein resection may be carried out. Prognostic factors after resection for bile duct cancer include positive surgical margins, especially in the ductal stump; lymph node metastasis; perineural invasion; and combined vascular resection due to portal vein and/or hepatic artery invasion. For patients with suspected gallbladder cancer, laparoscopic cholecystectomy is not recommended, and open cholecystectomy should be performed as a rule. When gallbladder cancer invading the subserosal layer or deeper has been detected after simple cholecystectomy, additional resection should be considered. Prognostic factors after resection for gallbladder cancer include the depth of mural invasion; lymph node metastasis; extramural extension, especially into the hepatoduodenal ligament; perineural invasion; and the degree of curability. Pancreaticoduodenectomy is indicated for ampullary carcinoma, and limited operation is also indicated for carcinoma in adenoma. The prognostic factors after resection for ampullary carcinoma include lymph node metastasis, pancreatic invasion, and perineural invasion.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Survival of patients with resection of gallbladder cancer, bile duct cancer, and cancer of the papilla of Vater. Percentages show 5-year survival rates.GB, Cancer of the gallbladder, BD, cancer of the bile duct; PV, cancer of the papilla of Vater. Postoperative survival after resection of biliary cancer
Fig. 2
Fig. 2
Anatomical nomenclature of the biliary tract (Japanese Society of Biliary Surgery. Classification of biliary tract carcinoma. Second English edition. Tokyo: Kanehara; 2004), with permission
Fig. 3
Fig. 3
Modified Bismuth-Corlette classification (from Bismuth H, Nakache R, Diamond T. Management strategies in resection for hilar cholangiocarcinoma. Ann Surg 1992;215:31–8.), with permission

References

    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '12541042', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/12541042/'}]}
    2. Nagakawa T, Kayahara M, Ikeda S, Futakawa, S, Kakita A, Kawarada H, et al. Biliary tract cancer treatment: results from the Biliary Tract Cancer Statistics Registry in Japan. J Hepatobiliary Pancreat Surg 2002;9:569–75. - PubMed
    1. None
    2. Japanese Society of Biliary Surgery. Classification of biliary tract carcinoma. Second English edition. Tokyo: Kanehara; 2004.
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PMC', 'value': 'PMC1242367', 'is_inner': False, 'url': 'https://pmc.ncbi.nlm.nih.gov/articles/PMC1242367/'}, {'type': 'PubMed', 'value': '1309988', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/1309988/'}]}
    2. Bismuth H, Nakache R, Diamond T. Management strategies in resection for hilar cholangiocarcinoma. Ann Surg 1992;215:31–8. - PMC - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PMC', 'value': 'PMC2794351', 'is_inner': False, 'url': 'https://pmc.ncbi.nlm.nih.gov/articles/PMC2794351/'}, {'type': 'PubMed', 'value': '18274838', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/18274838/'}]}
    2. Takada T, Miyazaki M, Miyakawa S, Tsukada K, Nagino M, Kondo S, et al. Purpose, use, and preparation of clinical practice guidelines for the management of biliary tract and ampullary carcinomas. J Hepatobiliary Pancreat Surg 2008;15:2–6. - PMC - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PMC', 'value': 'PMC1422074', 'is_inner': False, 'url': 'https://pmc.ncbi.nlm.nih.gov/articles/PMC1422074/'}, {'type': 'PubMed', 'value': '11573044', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/11573044/'}]}
    2. Jarnagin WR, Fong Y, DeMatteo RP, Gonen M, Burke EC, Bodniewicz BS J, et al. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg 2001;234:507–17. - PMC - PubMed

Publication types

LinkOut - more resources